Skip to content

Post COVID 19 illness and Homoeopathy

Master protocol for open label exploratory multi-centric study on homoeopathic treatment of post COVID 19 illness

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045738
Enrollment
400
Registered
2022-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: U07-

Interventions

Intervention1: Indicated homoeopathic medicines: Indicated homoeopathic medicines in decimal / centesimal potency will be prescribed as per the principles of Homoeopathy for a period 8 weeks. Dosage w

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: After more than 4 weeks after a positive test for SARS-CoV-2(RTPCR / Rapid antigen test/ IgM antibodies against SARS-CoV-2) AND Reports complaints dating back to COVID-19 illness The cases will be included in 3 parallel study sets: Repeat testing has been done at least 10 days after the first test and the patient has been identified to be positive for SARS-CoV-2 antigens; Repeat testing at least 10 days after the first test has been done and the patient has been identified to be negative for SARS-CoV-2 antigens; No repeat antigen testing has been done

Exclusion criteria

Exclusion criteria: Oxygen saturation SPO2below 95% in room air; Pre-existing pulmonary conditions such as bronchial asthma, COPD, etc. ; Patients on regular bronchodilators, or respiratory medicines through inhaler or nebulizer (self reported treatment history); Suffering from chronic life-threatening condition(s) requiring repeated hospitalizations / tertiary care treatments such as pre-existing malignancy, chronic renal failure, chronic liver failure, uncontrolled diabetes or uncontrolled Hypertension or any other complaint as per the discretion of the treating physician which may jeopardize patient participation in the study; patients on steroids during last 03 months

Design outcomes

Primary

MeasureTime frame
Days to resolution of symptoms Change in symptom severity Overall change in patient health Development of new symptomsTimepoint: every week for 8 weeks

Secondary

MeasureTime frame
Compilation of profile of patients seeking homoeopathic treatment for post acute COVID ââ?¬â?? 19 in terms of their disease profile, pre-existing health status and treatment preferences in the recent pastTimepoint: 8 weeks

Countries

India

Contacts

Public ContactDr Renu Mittal

Central Council for Research in Homoeopathy

drdivyataneja@gmail.com9810305068

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026